Home / Resource Library / ANTI-CD19 CHIMERIC ANTIGEN RECEPTOR T-CELLS THERAPY IS EFFECTIVE IN SECONDARY CNS LYMPHOMA REFRACTORY TO HIGH-DOSE METHOTREXATE-BASED CHEMOTHERAPYANTI-CD19 CHIMERIC ANTIGEN RECEPTOR T-CELLS THERAPY IS EFFECTIVE IN SECONDARY CNS LYMPHOMA REFRACTORY TO HIGH-DOSE METHOTREXATE-BASED CHEMOTHERAPY ICML 2025